Published: Aug 30, 2013 4:54 PM EDT
Updated: Aug 30, 2013 6:57 PM EDT

FORT MYERS, Fla. - Scientists with the Kanzius Cancer Research Foundation, started by a part-time Sanibel resident, have made another big step toward their goal curing cancer.

"We've taken the research from a petri dish, to small laboratory animals to now large laboratory animals," said Mark Neidig, Executive Director of the foundation.

Neidig, in town to speak with board members, spoke exclusively with WINK News.

The last time we told you about the Kanzius foundation, scientists were ready to move their testing to larger animals. But first, they needed a machine large enough to treat humans.

"We have large machines that are capable of treating humans, that are now doing large animal studies," Neidig said.

Tiny metal particles are injected into the body and attach themselves to cancer cells. Radiowaves are used o heat the particles, in turn killing the cancer.

Since we last spoke, scientists have figured out how to enbed the metal particles within the center of the cell and not just on the surface.

"The nucleus houses the DNA of the cell," said Neidig, "so if you can kill the brains from the on-set, that's an even greater success rate."

Neidig says the test on smaller animals killed 100% of the cancer cells with no side effects.

The original machine was created by the late John Kanzius, a part-time Sanibel resident who died of cancer in 2009. But before he passed he made an incredible discovery.

Sick from his chemo treatments one night, the former TV and Radio Station engineer had an idea: harness radio waves to kill cancer cells.

He got out of bed, went to the garage, and went to work. He built a radio wave machine, using his wife's pots and pans and a ham radio. Despite no medical background or college degree Kanzius ultimately invented a prototype of a machine now located at MD Anderson Cancer Center in Houston.

"John's idea was to develop a better way to treat cancer. One that doesn't have those barbaric side effects that are so often associated with it," Neidig said.

"Very seldom do you ever hear of a breakthrough that takes place that doesn't have some kind of a toxicity."

Once researchers feel they have adequate data they will go to the FDA to seek approval for human testing.

If you want to donate to the Kanzius Cancer Research Foundation head to: http://www.kanziuscancerresearch.org/donate